Table 3.
Pre‐metformin HbA1c <8% (1770 patients) | Pre‐metformin HbA1c >8% (1330 patients) | |||||||
---|---|---|---|---|---|---|---|---|
HbA1c values | Estimate | 95% CI | p | HbA1c values | Estimate | 95% CI | p | |
BRB‐PDC | ||||||||
0–49% | 1425 | Reference | — | — | 825 | Reference | — | — |
50–59% | 271 | 0.009 | −0.094, 0.112 | 0.859 | 221 | −0.129 | −0.297, 0.039 | 0.133 |
60–69% | 300 | −0.102 | −0.190, −0.014 | 0.024 | 197 | −0.278 | −0.450, −0.106 | 0.002 |
70–79% | 371 | −0.124 | −0.206, −0.042 | 0.003 | 265 | −0.373 | −0.518, −0.227 | <0.001 |
80–89% | 616 | −0.127 | −0.200, −0.053 | <0.001 | 478 | −0.534 | −0.666, −0.403 | <0.001 |
≥90% | 2913 | −0.151 | −0.216, −0.087 | <0.001 | 2036 | −0.456 | −0.572, −0.340 | <0.001 |
BRB‐PDC, biological response‐based proportion of days covered; CI, confidence interval; HbA1c, glycated haemoglobin.